...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Abstracts 4 of 4: Apabetalone (RVX-208) Reduces ACE2 Expression in Human Cell Culture Systems, Which Could Attenuate SARS-CoV-2 Viral Entry

Does anyone know if therapeutics clinical trials running independently from vaccine clinical trials?

I assume apabetalone falls under therapeutics...apabetalone attenuates SARS-CoV-2 Viral Entry..Apabetalone reduces ACE2 gene expression.

Here is the COVID 19 Vaccine Tracker:https://covid19.trackvaccines.org/

Cannot find trials for therapeutics.

 

Koo

 



5
Nov 10, 2020 09:47AM
3
Nov 10, 2020 01:00PM
1
Nov 10, 2020 01:17PM
4
Nov 10, 2020 02:48PM
1
Nov 10, 2020 03:08PM
3
Nov 10, 2020 06:26PM
4
Nov 10, 2020 07:02PM
Share
New Message
Please login to post a reply